Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Current Assets: 2019-2025

Historic Current Assets for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to $475.2 million.

  • CureVac N.V's Current Assets rose 75.39% to $475.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $475.2 million, marking a year-over-year increase of 75.39%. This contributed to the annual value of $562.5 million for FY2024, which is 9.29% up from last year.
  • Latest data reveals that CureVac N.V reported Current Assets of $475.2 million as of Q2 2025, which was down 3.70% from $493.4 million recorded in Q1 2025.
  • CureVac N.V's 5-year Current Assets high stood at $1.9 billion for Q2 2021, and its period low was $270.9 million during Q2 2024.
  • Its 3-year average for Current Assets is $534.8 million, with a median of $538.6 million in 2023.
  • Per our database at Business Quant, CureVac N.V's Current Assets spiked by 160,254.88% in 2021 and then crashed by 63.41% in 2022.
  • CureVac N.V's Current Assets (Quarterly) stood at $1.1 billion in 2021, then tumbled by 44.59% to $595.9 million in 2022, then fell by 13.62% to $514.7 million in 2023, then grew by 9.29% to $562.5 million in 2024, then surged by 75.39% to $475.2 million in 2025.
  • Its Current Assets was $475.2 million in Q2 2025, compared to $493.4 million in Q1 2025 and $562.5 million in Q4 2024.